Skip to main content
. 2021 Feb 25;60(12):5620–5629. doi: 10.1093/rheumatology/keab160

Fig. 1.


Fig. 1

Lupus psychosis sample showing GABABR positivity on fixed cell-based assay

Immunostaining of commercial cell-based assay (af) showing HEK cells expressing: (a) GABABR (R1/R2), (b) DPPX, (c) LGI1, (d) AMPAR1/2, (e) CASPR2, (f) NMDAR. Sera were diluted 1:10 and antibody binding visualised with goat anti-human IgG. Note the surface binding of the GABABR (a) and the nuclear staining of the NMDAR cells, which are strongly permeabilised (f), and seen in all ANA-positive SLE patients (g, h). Higher magnifications of GABABR and NMDAR expressing cells, taken from a, f. AMPA: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CASPR2: contactin associated protein 2; DPPX: dipeptidyl aminopeptidase-like protein 6; GABA: gamma-Aminobutyric acid; HEK: human epithelial kidney; LGI1: leucine-rich glioma inactivated 1; NMDA: N-methyl-D-aspartate; SLE: systemic lupus erythematosus.